:: Volume 31, Issue 5 (12-2023) ::
Journal of Ilam University of Medical Sciences 2023, 31(5): 122-127 Back to browse issues page
Strategic and executive recommendations in the field of radiation risks for family members of thyroid cancer patients treated with radioactive iodine
Seyed Salman Zakariaee *
Dept of Medical Physics, Faculty of Paramedical Sciences, Ilam University of Medical Sciences, Ilam, Iran , salman_zakariaee@yahoo.com
Abstract:   (366 Views)
Radiation safety is one of the main concerns in nuclear medicine treatments. After the discharge of thyroid cancer patients treated with radioactive iodine, the radiation exposure to family members of the patients is one of the main concerns of the patients and the society, which in some cases can cause the patient to be stigmatized and not receive the necessary care and emotional support from family and community members. Therefore, in order to reduce the side effects of this issue through the most essential strategic and executive recommendations mentioned in this policy summary, the following hint can be pointed out: training and raising the awareness of medical staff, patients, and society regarding the concepts related to ionizing radiation, permissible radiation dose, radiation hazards, principles of radiation protection, absorbed radiation dose, and factors affecting the absorbed radiation dose during therapeutic and supportive care of the patient under treatment, eliminating the influence of socio-economic factors, lifestyle and literacy level of the patient's family members on the compliance of caregivers with safety recommendations and eventually the radiation exposure to the family members of the patients.
Keywords: Radiation dose to family members, Thyroid cancer, Nuclear medicine, Iodine therapy, 131I
Full-Text [PDF 419 kb]   (188 Downloads)    
Type of Study: case report | Subject: radiobiology
Received: 2023/10/1 | Accepted: 2023/12/6 | Published: 2023/12/6

Ethics code: 36/003NC1402


XML   Persian Abstract   Print



Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 31, Issue 5 (12-2023) Back to browse issues page